Franklin Resources Inc. Has $576,000 Holdings in Harrow, Inc. (NASDAQ:HROW)

Franklin Resources Inc. trimmed its stake in Harrow, Inc. (NASDAQ:HROW) by 94.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,817 shares of the company’s stock after selling 229,628 shares during the period. Franklin Resources Inc.’s holdings in Harrow were worth $576,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the stock. First Turn Management LLC bought a new position in shares of Harrow during the third quarter worth about $14,683,000. Assenagon Asset Management S.A. bought a new position in Harrow during the 3rd quarter worth approximately $8,572,000. Charles Schwab Investment Management Inc. lifted its position in shares of Harrow by 195.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 251,629 shares of the company’s stock worth $11,313,000 after purchasing an additional 166,602 shares during the period. Braidwell LP boosted its stake in shares of Harrow by 47.9% in the 3rd quarter. Braidwell LP now owns 439,638 shares of the company’s stock valued at $19,766,000 after purchasing an additional 142,450 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Harrow during the third quarter worth $5,864,000. 72.76% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on HROW. B. Riley cut their price target on shares of Harrow from $73.00 to $69.00 and set a “buy” rating on the stock in a research report on Wednesday, December 4th. Lake Street Capital raised their target price on Harrow from $45.00 to $55.00 and gave the stock a “buy” rating in a research note on Friday, October 4th. Finally, Craig Hallum boosted their price target on Harrow from $45.00 to $65.00 and gave the company a “buy” rating in a research note on Friday, October 4th.

Harrow Trading Down 0.4 %

Shares of Harrow stock opened at $33.38 on Tuesday. The stock has a market capitalization of $1.19 billion, a PE ratio of -35.51 and a beta of 0.69. Harrow, Inc. has a 52 week low of $9.13 and a 52 week high of $59.23. The stock has a 50 day moving average price of $42.04 and a two-hundred day moving average price of $37.46. The company has a debt-to-equity ratio of 3.23, a quick ratio of 1.44 and a current ratio of 1.55.

About Harrow

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.